Effect of ozone on susceptibility to respiratory viral infection and virus-induced cytokine secretion

Environmental Toxicology and Pharmacology

Volumn 6, Issue 4, 1998, Pages 257-265

  Becker, Susanne ^a,c   Soukup, Joleen M ^a   Reed, William ^b   Carson, J ^b   Devlin, Robert B ^a   Noah, Terry L ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Airway epithelial cells; Cytokine production; IL 6; IL 8; Ozone; RSV infection

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; OZONE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS INFECTIVITY;

EID: 0032442302     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(98)00043-X     Document Type: Article

References (40)

1. Baggolini, M., Walz, A., Kunkel, S.L., 1989. Neutrophil-activating peptide-1/Interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84, 1045-1049.
2. Becker, S., Soukup, J., Yankaskas, J.R., 1992. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages. Am. J. Respir. Cell Mol. Biol. 6, 369-374.
3. Becker, S., Horen, H.S., Henke, D., 1993. IL-8 expression and production by uncultured nasal epithelial cells and its enhancement by viral infection and by TNF and IL-1. Am. J. Respir. Cell. Mol. Biol. 8, 20-27.
4. Bocci, V., 1992. Ozonization of blood for the therapy of viral diseases and immunodeficiencies. A hypothesis. Med. Hypotheses 39, 30-34.
5. Carpendale, M.T., Freeberg, J.K., 1991. Ozone inactivates HIV at noncytotoxic concentrations. Antivir. Res. 16, 281-292.
6. Clarke, S.K.R., 1978. Respiratory synytial virus infection: admission to hospitals in industrial, urban and rural areas. Br J. Med. 2, 796-798.
7. Coffin, D.L., Gardner, D.E., 1972. Interaction of biological agents and chemical pollutants. Ann. Occup. Hyg. 15, 219-223.
8. Denny, F.M., Clyde, W.A., 1986. Acute lower respiratory tract infections in nonhospilalized children. J. Pediatr. 108, 635-646.
9. Devlin, R.B., McDonnell, W.F., Mann, R., et al., 1991. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am. J. Respir. Cell. Mol. Biol. 4, 72-81.
10. Devlin, R.B., McKinnon, K.P., Noah, T., et al., 1994. Cytokine and fibronectin production by human alveolar macrophages and airway epithelial cells exposed to zone in vitro. Am. J. Physiol. 266, L612-L619.
11. Devlin, R.B., McKinnon, K.P., Reed, W., et al., 1995. In vitro ozone exposure induces increased expression of mRNA coding for IL-6 and alpha-chemokines, but not beta-chemokines in human airway epithelial cells. In: J. Albrecht (Ed.), Proceedings of the Fifth International Inhalation Symposium. ILSI Press.
12. Falsey, A.R., Treanor, J.J., Betts, R.F., et al., 1992. Viral respiratory infections in the institutionalized elderly: clinical and epidemiological findings. J. Am. Geriatr. Soc. 40, 115-119.
13. Fairchild, G.A., 1977. Effects of ozone and sulphur dioxide on virus growth in mice. Arch. Environ. Health 32, 28-33.
14. Fleming, D.M., Cross, K.W., 1993. Respiratory syncytial virus or influenza? Lancet 342, 2507-2510.
15. Friedman, L.I., Stromberg, R.R., 1993. Viral inactivation and reduction in cellular blood products. Rev. Fr. Transf. Hemobiol. 36, 83-91.
16. Garofalo, R., Sabry, M., Jamaluddin, M., et al., 1996. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus in alveolar epithelial cells: nuclear translocation of RelA transcription factor as a mechanism producing airway mucosal inflammation. J. Virol. 70, 8773-8781.
17. Gilmour, M.I., Park, P., Selgrade, M.J.K., 1993. Ozone-enhanced pulmonary infection with Streptococcus zooepidemicus. Am. Rev. Respir. Dis. 147, 753-760.
18. Harder, S.D., Harris, D.T., House, D., et al., 1990. Inhibition of human natural killer cell activity following in vitro exposure to ozone. Inhal. Toxicol. 2, 161-173.
19. Heinrich, P.C., Castell, J.V., Andus, T., 1990. Inlerleukin-6 and the acute phase response. Biochem. J. 265, 621-636.
20. Henderson, F.W., Hu, S.-C., Collier, A.M., 1978. Pathogenesis of respiratory syncytial virus infection in ferret and the fetal tracheas in organ culture. Am. Rev. Respir. Dis. 118, 29-37.
21. Henderson, F.W., Dubo, E.J., Harde, S., et al., 1988. Experimental rhinovirus infectoin in human volunteers exposed to ozone. Am. Rev. Respir. Dis. 137, 1124-1128.
22. Hierholzer, J.C., Tannock, G.A., 1986. Respiratory syncytial virus: a review of the virus, its epidemiology, immune response and laboratory diagnosis. Aust. Pediatr. 22, 77-82.
23. Jacab, G.J., Himeleski, R.R., 1988. Reduction of influenza virus pathogenesis by exposure to 0.5 ppm ozone. J. Toxicol. Environ. Health 23, 455-472.
24. Jaspers, I., Flescher, E., Chen, L.C., 1997. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. Am. J. Physiol. 272, 504-511.
25. Kunkel, S.L., Standiford, T., Kashara, K., Strieter, R.M., 1991. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp. Lung Res. 17, 17-23.
26. Landegren, U., 1988. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Application to detection of lymphokines and cell surface antigens. J. Immunol. Methods 67, 379-388.
27. Mathur, U., Bentley, D.W., Hall, C.B., 1980. Concurrent respiratory syncytial virus and influenza A infection in the institutionalized elderly and chronically ill. Ann. Intern. Med. 93, 49-52.
28. Matsusaka, T., Fujikawa, K., Nishio, Y., et al., 1993. Transcription factors NF-IL6 an NF-kB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. 90, 10193-10197.
29. McIntosh, K., Chanock, R.M., 1985. Respiratory syncytial virus. Virology 54, 1285-1304.
30. McKinney, W.J., Dreher, K.L., Jascot, R.H., Baumann, H., Costa, D.L., 1994. The role of IL-6 in Ozone-induced tolerance. Respir. Crit. Care Med. 149, 157A.
31. McKinnon, K.P., Madden, M., Noah, T.L., et al., 1993. In vitro ozone exposure increases release of arachidonic acid products from a human bronchial epithelial cell line. Toxicol. Appl. Pharmacol. 118, 215-233.
32. Noah, T.L., Becker, S., 1993. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 265, 472-478.
33. Noah, T.T., Henderson, F.W., Wortman, I.A., et al., 1995. Nasal cytokine production in acute upper respiratory infection of children. J. Infect. Dis. 171, 584-592.
34. Ramsay, A.J., Husband, A.J., Ramshaw, I.A., et al., 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561-563.
35. Reddel, R.R., Ke, Y., Gerwin, B.I., et al., 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48, 1904-1909.
36. Ruef, C., Coleman, D.L., 1990. Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev. Inf. Dis. 12, 41-48.
37. Schreck, R., Rieber, P., Baeuerle, P.A., 1991. Reactive oxygen intermediates are apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
38. Selgrade, M.K., Illing, J.W., Starnes, D.M., Stead, A.G., Menache, M.G., Stevens, M.A., 1988. Evaluation of effects of ozone exposure on influenza infection in mice using several indicators of susceptibility. Fund Appl. Toxicol. 1, 169-180.
39. Van Loveren, H., Rombout, P.K.A., Wagemaar, Sj.Sc., et al., 1988. Effect of ozone on the defense to a respiratory Listeria monocytogenes infection in the rat. Toxicol. Appl Pharmacol. 94, 374-393.
40. Wolcott, J.A., Zee, Y.C., Osebold, J.W., 1982. Exposure to ozone reduces influenza disease severity and alters distribution of influenza viral antigens in murine lung. Appl. Environ. Biol. 44, 723-731.